The novelty of our study lies in the comparison of four markers of cardiovascular risk: dyslipidaemia [lp(a)], insulin reistance (leptin), inflammation (hs-CRP) and matrix remodelling (PAPP-A), as possible predictors of plaque instability. Here, LEP is linked to inherited lipid metabolism disorder.